Comparing five extended-depth-of-focus intraocular lenses and one standard monofocal lens for cataract surgery
Official title: Visual Performance, Patient Satisfaction, and Quality of Vision Outcomes in Presbyopia-Correcting IOLs: A Prospective Clinical Study
Run by Augenklinik Ahaus G + H GmbH & Co. KG · NCT07051720 · Data updated 2026-11-12
This test compares five extended-depth-of-focus intraocular lenses and one standard monofocal lens in adults having cataract surgery in both eyes to see which provides the best distance, intermediate, and near vision and reduces the need for glasses.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years to 85 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Augenklinik Ahaus G + H GmbH & Co. KG Academic / other |
| Locations | 1 site (Ahaus, North Rhine-Westphalia) |
| Status | Recruiting |
| Started | April 12, 2022 |
| Main results expected | October 2025 |
| Study ends | January 2026 |
| Registry record updated | July 4, 2025 |
| Trial ID | NCT07051720 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 22 to 85 requiring bilateral cataract surgery with regular corneal astigmatism under 1.0 diopter and expected postoperative BCDVA of 0.8 decimal or better are the ideal candidates.
✕Probably not a fit
Patients with prior corneal refractive surgery, irregular astigmatism, significant ocular comorbidities, pupillary abnormalities, or IOL power needs outside +10.0 D to +30.0 D are unlikely to be eligible or to benefit from the lenses tested.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, interventional comparison enrolls adults undergoing bilateral cataract surgery who receive one of six intraocular lens (IOL) models implanted in both eyes. The five enhanced-depth-of-focus (EDOF) lenses (TECNIS Eyhance, AcrySof IQ Vivity, LuxSmart, Rayner EMV, Eyecryl SERT) are compared head-to-head against a standard monofocal lens (CT ASPHINA 409M). Outcomes include uncorrected and best-corrected visual acuity at multiple distances, patient-reported satisfaction, and spectacle dependence. Participants must meet ocular health criteria such as regular corneal astigmatism <1.0 D and be within the available IOL power range.
Why it matters
Potential benefit: If successful, the trial could identify which lens designs give the best range of clear vision and reduce reliance on glasses after cataract surgery.
How similar studies have gone: Previous studies comparing EDOF and monofocal IOLs have generally reported improved intermediate vision and reduced spectacle dependence with EDOF designs, but direct head-to-head comparisons across these specific lenses are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Bilateral implantation of the same intraocular lens (IOL) model * Expected postoperative best-corrected distance visual acuity (BCDVA) of 0.8 (decimal) or better * Regular corneal astigmatism less than 1 diopter Exclusion Criteria: * Endothelial cell density \< 2,000 cells/mm² * Required IOL power for emmetropia falls outside the available range of +10.0 D to +30.0 D * Pupillary abnormalities * Intraocular inflammation * Recent ocular trauma or ocular surgery that is unresolved/unstable, or which may impair visual outcomes or increase patient risk * History of corneal refractive surgery (e.g., LASIK, LASEK, PRK) * Irregular astigmatism, as well as corneal abnormalities or opacities * Conditions associated with an increased risk of zonular rupture, including capsular or zonular anomalies that may lead to IOL decentration or tilt, such as pseudoexfoliation syndrome, trauma, Marfan syndrome, among others * Systemic or ocular diseases, or medications, that may impair vision, increase surgical risk, or confound study outcomes * Clinically significant dry eye disease affecting visual function * Anticipated need for retinal laser treatment or any other ocular surgical intervention during the study period * Pregnancy, planned pregnancy, breastfeeding, or any condition associated with hormonal fluctuations that may induce refractive changes * Continuous contact lens wear within the past 4 weeks * Inability to understand and/or complete study questionnaires * Advanced glaucoma with visual field defects * Age-related macular degeneration (exudative or geographic form)
Where it's running
-
Augenklinik Ahaus
Ahaus, North Rhine-Westphalia, Germany Recruiting
Study contacts
- Principal investigator: dr. med. (Univ. Bud.) Matthias Gerl, MD — Augenklinik Ahaus
- Study coordinator: dr. med. (Univ. Bud.) Matthias Gerl, MD
- Email: m.gerl@augenklinik.de
- Phone: +49 (2561) 9555-301
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Toric add-on lens to reduce astigmatism after corneal transplant and cataract surgery
This will try a toric add-on lens placed in the eye’s sulcus to reduce persistent high astigmatism in people who have had keratoplasty and cataract surgery.
-
Heads-up display guidance for aligning toric intraocular lenses
This will test whether a digital heads-up guidance system helps surgeons place toric intraocular lenses more accurately during cataract surgery.
-
Helioscope optical biometer combining LED corneal topography and SS-OCT
This study will test whether the Helioscope can take accurate corneal shape and eye-length measurements in adults with cataracts to help choose the right intraocular lens power.
-
Using asymmetrical toric intraocular lenses to improve vision for people with irregular corneas
This will test a custom asymmetrical toric intraocular lens during cataract surgery to reduce irregular astigmatism and improve vision in adults with irregular corneas.
-
Comparing two trifocal toric intraocular lenses for cataract surgery.
This trial will test two different trifocal toric intraocular lenses to see which gives better intermediate-distance vision and satisfaction for adults with cataracts and regular corneal astigmatism.
-
Clareon PanOptix versus AcrySof PanOptix for contrast vision after cataract surgery
This study will try Clareon PanOptix in one eye and AcrySof PanOptix in the other to see which lens gives better contrast vision three months after cataract surgery for adults seeking presbyopia correction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.